Evidence map›Paper›PMID 42757666›Full record

ArticleBasic & clinical pharmacology & toxicology2026

Doxorubicin and 4-Hydroperoxycyclophosphamide Alter Mitochondrial Dynamics and miR-34 Expression in Spermatogonia and Spermatocytes In Vitro.

Hülya Öztatlıcı, Mahmut Kemal Özbilgin, Rukiye Betül Çolaksel, Suna Karadeniz Saygılı, Mustafa Öztatlıcı

Abstract read
In one paragraph

Article in Basic & clinical pharmacology & toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hülya ÖztatlıcıDepartment of Histology and Embryology, Faculty of Medicine, Gaziantep University, Gaziantep, Türkiye.ORCID https://orcid.org/0000-0002-6749-9665
Mahmut Kemal ÖzbilginDepartment of Histology and Embryology, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Türkiye.ORCID https://orcid.org/0000-0001-6627-5443
Rukiye Betül ÇolakselDepartment of Histology and Embryology, Faculty of Medicine, Gaziantep Islam Science and Technology University, Gaziantep, Türkiye.ORCID https://orcid.org/0009-0002-5256-1259
Suna Karadeniz SaygılıDepartment of Histology and Embryology, Faculty of Medicine, Kütahya Health Sciences University, Kütahya, Türkiye.ORCID https://orcid.org/0000-0003-1704-3720
Mustafa ÖztatlıcıDepartment of Histology and Embryology, Faculty of Medicine, Gaziantep Islam Science and Technology University, Gaziantep, Türkiye.ORCID https://orcid.org/0000-0001-9914-7122

Funding

Manisa Celal Bayar University Scientific Researches Funding Commission 2021-044
6 · The paper itself

Abstract

Doxorubicin (DOX) and cyclophosphamide (CP) are widely used chemotherapeutic agents with known gonadotoxic effects. Since miRNAs play a key role in the transcriptional regulation of spermatogenesis, they are suggested as biomarkers for male infertility. This study aimed to investigate changes in vitro the expression of proteins related to mitochondrial dynamics, apoptotic cell profiles and cell cycle distribution after treating mouse spermatogonia and spermatocytes with DOX and 4-hydroperoxycyclophosphamide (4-HC). Additionally, we also aimed to evaluate the correlation between mitochondrial function-related miR-34 family expression and mitochondrial dynamics in both cells. Mitochondrial fusion, fission, mitophagy and apoptosis markers were analysed by immunocytochemistry and qPCR. miR-34 family expressions were assessed by qPCR. Apoptosis profiles and cell cycle distributions were determined using flow cytometry. We found that DOX and 4-HC increased the percentage of cells in S and G2/M phases and apoptosis levels. Mitochondrial fusion and mitophagy gene expressions decreased, whereas fission gene expression increased. Moreover, miR-34a expression rose, whereas miR-34b and miR-34c expressions significantly decreased after treatment. These miR-34 family expression changes correlated with mitochondrial dynamics-related gene expressions, suggesting a potential role of the miR-34 family in mitochondrial dysfunction.

Indexed as

CyclophosphamideDoxorubicinMicroRNAsMitochondrial DynamicsSpermatocytesSpermatogoniaAnimalsApoptosisCell CycleGene Expression RegulationMaleMiceMitochondriaMitophagyCyclophosphamideDoxorubicinMicroRNAsMIRN34a microRNA, mouseperfosfamidechemotherapymiR‐34mitochondrial dynamicsspermatagoniumspermatocyte

Identifiers

PMID42757666
PMCPMC13587110

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.